Andrew Kung Selected Research

Andrew Kung Research Topics

4	Neoplasms (Cancer) 01/2020 - 10/2017
1	COVID-19 11/2023
1	Post-Acute COVID-19 Syndrome 11/2023
1	Autoimmune Diseases (Autoimmune Disease) 06/2023
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 06/2023
1	Autoimmune Hepatitis 06/2023
1	Non-alcoholic Fatty Liver Disease 06/2023
1	Fibrosis (Cirrhosis) 06/2023
1	Myocardial Ischemia (Ischemic Heart Diseases) 03/2022
1	Myocardial Infarction 03/2022
1	Hepatoblastoma 01/2020
1	Wilms Tumor (Wilm's Tumor) 01/2020
1	Melanoma (Melanoma, Malignant) 01/2019
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2019
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2018
1	Paraganglioma (Paragangliomas) 01/2018
1	Pheochromocytoma 01/2018
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 10/2017
1	Glioblastoma (Glioblastoma Multiforme) 01/2009
1	Hypoxia (Hypoxemia) 02/2005

1	Neutralizing AntibodiesIBA 11/2023
1	Broadly Neutralizing AntibodiesIBA 11/2023
1	COVID-19 VaccinesIBA 11/2023
1	AutoantibodiesIBA 06/2023
1	2- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA 06/2023
1	AntibodiesIBA 06/2023
1	Peptides (Polypeptides)IBA 06/2023
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2019
1	2- ((3- ((4- ((5- (2- ((3- fluorophenyl)amino)- 2- oxoethyl)- 1H- pyrazol- 3- yl)amino)quinazolin- 7- yl)oxy)propyl)(ethyl)amino)ethyl dihydrogen phosphateIBA 01/2019
1	PND 1186IBA 01/2019
1	LigandsIBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	CytokinesIBA 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2019
1	PF-562271IBA 01/2019
1	Aurora Kinase BIBA 01/2019
1	CateninsIBA 01/2018
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2018
1	aspartylglutamateIBA 01/2018
1	Glycogen Synthase Kinase 3IBA 01/2018
1	Protein Isoforms (Isoforms)IBA 10/2017
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 10/2017
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2009
1	LuciferasesIBA 02/2005
1	Etoposide (VP 16)FDA LinkGeneric 02/2005
1	Messenger RNA (mRNA)IBA 02/2005

1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 03/2022
1	Percutaneous Coronary Intervention 03/2022
1	Therapeutics 01/2009